List of Tables
Table 1. Global Organoids Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Organoids Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Organoids Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Organoids Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Organoids Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Organoids Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Organoids Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Organoids Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Organoids Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Organoids Revenue by Company (2020-2025) & (US$ Million)
Table 11. Organoids Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Organoids Players by Revenue (US$ Million) in 2024
Table 13. Global Organoids Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Organoids by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organoids as of 2024)
Table 15. Global Organoids Companies Headquarters
Table 16. Date of International Companies Enter into Organoids Market
Table 17. Global Organoids Companies Product & Service
Table 18. Global Organoids Mergers & Acquisitions, Expansion Plans
Table 19. Thermo Fisher Scientific Corporation Information
Table 20. Thermo Fisher Scientific Description and Business Overview
Table 21. Thermo Fisher Scientific Organoids Product
Table 22. Thermo Fisher Scientific Organoids Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Thermo Fisher Scientific Revenue Proportion of Organoids by Product in 2024
Table 24. Thermo Fisher Scientific Revenue Proportion of Organoids by Application in 2024
Table 25. Thermo Fisher Scientific Revenue Proportion of Organoids by Geographic Area in 2024
Table 26. Thermo Fisher Scientific Recent Developments
Table 27. Merck Corporation Information
Table 28. Merck Description and Business Overview
Table 29. Merck Organoids Product
Table 30. Merck Organoids Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Merck Revenue Proportion of Organoids by Product in 2024
Table 32. Merck Revenue Proportion of Organoids by Application in 2024
Table 33. Merck Revenue Proportion of Organoids by Geographic Area in 2024
Table 34. Merck Recent Developments
Table 35. Corning Corporation Information
Table 36. Corning Description and Business Overview
Table 37. Corning Organoids Product
Table 38. Corning Organoids Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Corning Revenue Proportion of Organoids by Product in 2024
Table 40. Corning Revenue Proportion of Organoids by Application in 2024
Table 41. Corning Revenue Proportion of Organoids by Geographic Area in 2024
Table 42. Corning Recent Developments
Table 43. STEMCELL Technologies Corporation Information
Table 44. STEMCELL Technologies Description and Business Overview
Table 45. STEMCELL Technologies Organoids Product
Table 46. STEMCELL Technologies Organoids Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. STEMCELL Technologies Revenue Proportion of Organoids by Product in 2024
Table 48. STEMCELL Technologies Revenue Proportion of Organoids by Application in 2024
Table 49. STEMCELL Technologies Revenue Proportion of Organoids by Geographic Area in 2024
Table 50. STEMCELL Technologies Recent Developments
Table 51. Lonza Corporation Information
Table 52. Lonza Description and Business Overview
Table 53. Lonza Organoids Product
Table 54. Lonza Organoids Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Lonza Revenue Proportion of Organoids by Product in 2024
Table 56. Lonza Revenue Proportion of Organoids by Application in 2024
Table 57. Lonza Revenue Proportion of Organoids by Geographic Area in 2024
Table 58. Lonza Recent Developments
Table 59. Prellis Biologics Corporation Information
Table 60. Prellis Biologics Description and Business Overview
Table 61. Prellis Biologics Organoids Product
Table 62. Prellis Biologics Organoids Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Prellis Biologics Revenue Proportion of Organoids by Product in 2024
Table 64. Prellis Biologics Revenue Proportion of Organoids by Application in 2024
Table 65. Prellis Biologics Revenue Proportion of Organoids by Geographic Area in 2024
Table 66. Prellis Biologics Recent Developments
Table 67. amsbio Corporation Information
Table 68. amsbio Description and Business Overview
Table 69. amsbio Organoids Product
Table 70. amsbio Organoids Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. amsbio Revenue Proportion of Organoids by Product in 2024
Table 72. amsbio Revenue Proportion of Organoids by Application in 2024
Table 73. amsbio Revenue Proportion of Organoids by Geographic Area in 2024
Table 74. amsbio Recent Developments
Table 75. Tanwang Medical Corporation Information
Table 76. Tanwang Medical Description and Business Overview
Table 77. Tanwang Medical Organoids Product
Table 78. Tanwang Medical Organoids Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Tanwang Medical Revenue Proportion of Organoids by Product in 2024
Table 80. Tanwang Medical Revenue Proportion of Organoids by Application in 2024
Table 81. Tanwang Medical Revenue Proportion of Organoids by Geographic Area in 2024
Table 82. Tanwang Medical Recent Developments
Table 83. Ketu Medicine Corporation Information
Table 84. Ketu Medicine Description and Business Overview
Table 85. Ketu Medicine Organoids Product
Table 86. Ketu Medicine Organoids Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Ketu Medicine Revenue Proportion of Organoids by Product in 2024
Table 88. Ketu Medicine Revenue Proportion of Organoids by Application in 2024
Table 89. Ketu Medicine Revenue Proportion of Organoids by Geographic Area in 2024
Table 90. Ketu Medicine Recent Developments
Table 91. Chuangxin International Corporation Information
Table 92. Chuangxin International Description and Business Overview
Table 93. Chuangxin International Organoids Product
Table 94. Chuangxin International Organoids Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Chuangxin International Revenue Proportion of Organoids by Product in 2024
Table 96. Chuangxin International Revenue Proportion of Organoids by Application in 2024
Table 97. Chuangxin International Revenue Proportion of Organoids by Geographic Area in 2024
Table 98. Chuangxin International Recent Developments
Table 99. North America Organoids Revenue by Country (2020-2025) & (US$ Million)
Table 100. North America Organoids Revenue by Country (2026-2031) & (US$ Million)
Table 101. North America Organoids Revenue by Type (2020-2025) & (US$ Million)
Table 102. North America Organoids Revenue by Application (2020-2025) & (US$ Million)
Table 103. Asia-Pacific Organoids Revenue by Region (2020-2025) & (US$ Million)
Table 104. Asia-Pacific Organoids Revenue by Region (2026-2031) & (US$ Million)
Table 105. Asia-Pacific Organoids Revenue by Type (2020-2025) & (US$ Million)
Table 106. Asia-Pacific Organoids Revenue by Application (2020-2025) & (US$ Million)
Table 107. Europe Organoids Revenue by Country (2020-2025) & (US$ Million)
Table 108. Europe Organoids Revenue by Country (2026-2031) & (US$ Million)
Table 109. Europe Organoids Revenue by Type (2020-2025) & (US$ Million)
Table 110. Europe Organoids Revenue by Application (2020-2025) & (US$ Million)
Table 111. Latin America Organoids Revenue by Country (2020-2025) & (US$ Million)
Table 112. Latin America Organoids Revenue by Country (2026-2031) & (US$ Million)
Table 113. Latin America Organoids Revenue by Type (2020-2025) & (US$ Million)
Table 114. Latin America Organoids Revenue by Application (2020-2025) & (US$ Million)
Table 115. Middle East and Africa Organoids Revenue by Country (2020-2025) & (US$ Million)
Table 116. Middle East and Africa Organoids Revenue by Country (2026-2031) & (US$ Million)
Table 117. Middle East and Africa Organoids Revenue by Type (2020-2025) & (US$ Million)
Table 118. Middle East and Africa Organoids Revenue by Application (2020-2025) & (US$ Million)
Table 119. Organoids Key Raw Materials, Industry Status and Trend
Table 120. Organoids Key Raw Materials and Upstream Suppliers
Table 121. Organoids Clients Status and Trend
Table 122. Organoids Typical Clients
Table 123. Organoids Distributors
Table 124. Organoids Market Trends
Table 125. Organoids Market Drivers
Table 126. Organoids Market Challenges
Table 127. Organoids Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Organoids Product Picture
Figure 2. Global Organoids Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Organoids Revenue Market Share by Type in 2024 & 2031
Figure 4. Stem Cell Source Product Picture
Figure 5. Tumor Cell Source Product Picture
Figure 6. Global Organoids Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Organoids Revenue Market Share by Application in 2024 & 2031
Figure 8. Precision Medicine
Figure 9. Pharmaceutical R&D
Figure 10. Academics and Research Institutes
Figure 11. Organoids Report Years Considered
Figure 12. Global Organoids Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Organoids Market Size (2020-2031) & (US$ Million)
Figure 14. Global Organoids Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Organoids Revenue Market Share by Region (2020-2031)
Figure 16. Global Organoids Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Organoids Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Stem Cell Source of Organoids Revenue Market Share by Application, 2024 VS 2031
Figure 19. Tumor Cell Source of Organoids Revenue Market Share by Application, 2024 VS 2031
Figure 20. Organoids Revenue Share by Company (2024)
Figure 21. Organoids Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Stem Cell Source Revenue Proportion by Company in 2024
Figure 23. Tumor Cell Source Revenue Proportion by Company in 2024
Figure 24. North America Organoids Revenue 2020-2031 (US$ Million)
Figure 25. North America Organoids Revenue Market Share by Type (2020-2025)
Figure 26. North America Organoids Revenue Market Share by Application (2020-2025)
Figure 27. Asia-Pacific Organoids Revenue 2020-2031 (US$ Million)
Figure 28. Asia-Pacific Organoids Revenue Market Share by Region (2020-2031)
Figure 29. Asia-Pacific Organoids Revenue Market Share by Type (2020-2025)
Figure 30. Asia-Pacific Organoids Revenue Market Share by Application (2020-2025)
Figure 31. Europe Organoids Revenue Growth Rate 2020-2031 (US$ Million)
Figure 32. Europe Organoids Revenue Market Share by Country (2020-2031)
Figure 33. Europe Organoids Revenue Market Share by Type (2020-2025)
Figure 34. Europe Organoids Revenue Market Share by Application (2020-2025)
Figure 35. Latin America Organoids Revenue Growth Rate 2020-2031 (US$ Million)
Figure 36. Latin America Organoids Revenue Market Share by Country (2020-2031)
Figure 37. Latin America Organoids Revenue Market Share by Type (2020-2025)
Figure 38. Latin America Organoids Revenue Market Share by Application (2020-2025)
Figure 39. Middle East and Africa Organoids Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Middle East and Africa Organoids Revenue Market Share by Country (2020-2031)
Figure 41. Middle East and Africa Organoids Revenue Market Share by Type (2020-2025)
Figure 42. Middle East and Africa Organoids Revenue Market Share by Application (2020-2025)
Figure 43. Organoids Supply Chain (Upstream and Downstream Market)
Figure 44. Global Production Market Share of Organoids Raw Materials by Region in 2024
Figure 45. Organoids Distribution Channels
Figure 46. Global Organoids Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 47. Global Organoids Percentage 2020-2031: Online Sales VS Offline Sales
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed